免费报名最后一天！第二届医疗器械研发创新论坛

Core Viewpoint - The second Medical Device R&D Innovation Forum will be held during the Medtec China 2025 exhibition in Shanghai, focusing on product innovation pathways and implementation mechanisms [2][3]. Agenda Summary Morning Session - Opening remarks will commence at 09:30, followed by various presentations including: - Exploration of medical-engineering integration in research hospitals by Lei Juan, highlighting innovation and transformation [2] - Discussion on new interventional technologies and related patents by Cao Gangyi, CEO of Huanxin Medical [2] - Successful practices in building multi-level medical technology clusters presented by Wang Hanxuan, a Swiss PSI scientist [2] - Research on vascular injury repair and regenerative materials by Wang Kai from Nankai University [2] - Current status and innovative thoughts on ultrasonic energy surgical instruments by Feng Gengchao, founder of Shenzhen Segasys Medical Technology [2] - Development and transformation of Chro-Mg™ time-controlled degradable magnesium alloy by Shi Chen, CEO of InnoCo [2]. Afternoon Session - The afternoon will feature additional presentations starting at 13:30, including: - Overview of the entire medical device R&D process and overseas case studies by Zhao Qing, founder of Siyu MedTech [3] - Key points on medical device testing and compliance standards by Shi Daifeng, Technical Director at China Inspection Huatuo [4] - Applications and efficacy of PDRN (salmon-derived beauty injections) in aesthetic implants by Zhou Gui, General Manager of Beijing Lila Technology [4] - Discussion on fully degradable stents for diabetic below-knee artery intervention by Han Chen, co-founder of Beijing Haisheng Medical Devices [4] - Exploration of the starting point for medical device innovation incubation by Zhang Bowei, CTO of Vascular Cube Medical Device Incubation Platform [4] - Trends in vascular reduction technology presented by Wang Yang, founder and General Manager of Jintai Medical [4] - Applications and practices of common polymer biomaterials in implantable medical devices by Guan Zenggang, R&D Director at Haiwang Medical [4] - AI-assisted planning for structural heart interventional surgeries by Xue Zhenling, General Manager of Xixin Technology [4].